Technetium Tc-99m Sestamibi

锝[99mTc]甲氧异腈

Report date: 2025/11/25 17:06:37
NME

Base Information

Drug NameTechnetium Tc-99m Sestamibi
Drug Alias NameTechnetium (99mTc) sestamibi99mTc-sestamibiTechnetium[99mTc]SestamibiCardioliteMiraluma +[9] 
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Technetium > 99mTcDiagnostic agent (In vivo) > Radionuclide Imaging agent +[4] 
Mechanisms of ActionRadionuclide imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsBreast DiseasesMucocutaneous Lymph Node SyndromeCoronary Disease +[6] 
Global Approved IndicationsCardiomyopathies
Approved Indications in ChinaCardiomyopathies
Original Approved Country/TerritoryN/A
Original Approved Date1991/01/01
Country/TerritoryCanadaUnited StatesTaiwan +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBristol-Myers Squibb CompanyLantheus Medical Imaging Inc
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Texas MD Anderson Cancer CenterBristol-Myers Squibb CompanyHta Co Ltd +[4] 
Inactive CompaniesNational Cancer Institute
Active IndicationsBreast DiseasesCoronary DiseaseCardiomyopathies +[4] 
Inactive IndicationsMucocutaneous Lymph Node SyndromeNeoplasms

Other Information

ATC CodeV09GA01
Related LinksN/A